![]() |
|
|
Vol. 56, Issue 4, 768-774, October 1999
1 Subunit of the
-Aminobutyric
AcidA Receptor Reveals the Importance of Residue 101 in
Determining the Allosteric Effects of Benzodiazepine Site Ligands
Department of Pharmacology (S.M.J.D., M.D.) and Division of
Neuroscience (S.M.J.D.), Faculty of Medicine, University of Alberta,
Edmonton, Alberta, Canada; and Neurosciences Institute, Department of
Pharmacology and Neuroscience, Ninewells Hospital and Medical School,
University of Dundee, Dundee, Scotland (A.L.M., J.J.L.)
The
-aminobutyric acidA (GABAA) receptor
contains a binding site (or sites) for benzodiazepines and related
ligands. Previous studies have shown that the residue occupying
position 101 (rat numbering) of the
subunit is particularly
important in determining how some of these compounds interact with the
receptor. We have made multiple substitutions (F, Y, K, Q, and E) of
the histidine at this position of the rat
1 subunit and coexpressed
the mutant subunits with
2 and
2 subunits in
Xenopus oocytes. The effects of flunitrazepam,
Ro15-1788, and Ro15-4513 on GABA-gated currents were then examined
using electrophysiological techniques. Three substitutions (F, Y, and
Q) had little effect on the ability of flunitrazepam to potentiate
GABA-induced currents and had relatively modest effects on the
EC50 value of the flunitrazepam response. Other mutations
(K and E) resulted in drastic reduction of flunitrazepam recognition.
All substitutions also affected the EC50 values for Ro15-1788 and Ro15-4513, and some led to dramatic changes in their efficacy. For example, H101Y, H101K, and H101Q produced receptors at
which Ro15-1788 acted as a partial agonist (maximum potentiation of
164, 159, and 130%, respectively), whereas Ro15-4513 acted as a
partial agonist at H101F, H101K, and H101E (potentiation of 122, 138, and 110%, respectively) and an antagonist at H101Y and H101Q. These
results indicate that the characteristics of the residue at position
101 of the
1 subunit play a crucial role in determining the efficacy
of benzodiazepine-site ligands.
This article has been cited by other articles:
![]() |
L. M. Sharkey and C. Czajkowski Individually Monitoring Ligand-Induced Changes in the Structure of the GABAA Receptor at Benzodiazepine Binding Site and Non-Binding-Site Interfaces Mol. Pharmacol., July 1, 2008; 74(1): 203 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Tan, A. Gonthier, R. Baur, M. Ernst, M. Goeldner, and E. Sigel Proximity-accelerated Chemical Coupling Reaction in the Benzodiazepine-binding Site of {gamma}-Aminobutyric Acid Type A Receptors: SUPERPOSITION OF DIFFERENT ALLOSTERIC MODULATORS J. Biol. Chem., September 7, 2007; 282(36): 26316 - 26325. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Berezhnoy, Y. Nyfeler, A. Gonthier, H. Schwob, M. Goeldner, and E. Sigel On the Benzodiazepine Binding Pocket in GABAA Receptors J. Biol. Chem., January 30, 2004; 279(5): 3160 - 3168. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Sawyer, D. C. Chiara, R. W. Olsen, and J. B. Cohen Identification of the Bovine gamma -Aminobutyric Acid Type A Receptor alpha Subunit Residues Photolabeled by the Imidazobenzodiazepine [3H]Ro15-4513 J. Biol. Chem., December 13, 2002; 277(51): 50036 - 50045. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Williams and M. H. Akabas Benzodiazepines Induce a Conformational Change in the Region of the gamma -Aminobutyric Acid Type A Receptor alpha 1-Subunit M3 Membrane-Spanning Segment Mol. Pharmacol., November 1, 2000; 58(5): 1129 - 1136. [Abstract] [Full Text] |
||||
![]() |
M. Davies, J. G. Newell, J. M. C. Derry, I. L. Martin, and S. M. J. Dunn Characterization of the Interaction of Zopiclone with gamma -Aminobutyric Acid Type A Receptors Mol. Pharmacol., October 1, 2000; 58(4): 756 - 762. [Abstract] [Full Text] |
||||